Max Chan
Direttore Finanziario/CFO presso FORESEE PHARMACEUTICALS CO., LTD.
Posizioni attive di Max Chan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| JHL BIOTECH, INC. | Comptroller/Controller/Auditor | 20/10/2015 | - |
| Direttore Finanziario/CFO | 20/10/2015 | 01/05/2018 | |
| FORESEE PHARMACEUTICALS CO., LTD. | Direttore Finanziario/CFO | 07/10/2019 | - |
| Public Communications Contact | 07/10/2019 | - | |
| Himax Taiwan, Inc. | Direttore Finanziario/CFO | 08/03/2010 | - |
| Himax Media Solutions, Inc. | Direttore/Membro del Consiglio | 08/03/2010 | - |
| Himax Imaging Ltd. | Direttore/Membro del Consiglio | 08/03/2010 | - |
Wisepal Technologies, Inc.
 Wisepal Technologies, Inc. Electronics DistributorsDistribution Services Part of Himax Technologies, Inc., Wisepal Technologies, Inc. is a Taiwanese company that manufactures display drivers. The company is based in Miao-Li, Taiwan. Wisepal Technologies was acquired by Himax Technologies, Inc. on February 01, 2007 for $21.52 million. | Direttore/Membro del Consiglio | 08/03/2010 | - |
| Harvest Investments Ltd. | Direttore/Membro del Consiglio | 09/12/2010 | - |
| Himax Semiconductor Ltd. | Direttore/Membro del Consiglio | 09/12/2010 | - |
Storia della carriera di Max Chan
Precedenti posizioni note di Max Chan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OBI PHARMA, INC. | Direttore operativo | 01/01/2010 | - |
| Direttore Finanziario/CFO | 01/01/2010 | 01/01/2019 | |
| Public Communications Contact | 01/01/2010 | 01/01/2019 | |
| Corporate Officer/Principal | 01/01/2010 | - | |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Max Chan
| National Taiwan University | Masters Business Admin |
| University of Illinois | Graduate Degree |
Statistiche
Distribuzione geografica
| Taiwan | 13 |
| Stati Uniti | 3 |
| Regno Unito | 2 |
Posizioni
| Director of Finance/CFO | 6 |
| Director/Board Member | 5 |
| Corporate Officer/Principal | 4 |
Settori
| Health Technology | 5 |
| Electronic Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| HIMAX TECHNOLOGIES, INC. | Electronic Technology |
| INTEL CORPORATION | Electronic Technology |
| OBI PHARMA, INC. | Health Technology |
| FORESEE PHARMACEUTICALS CO., LTD. | Health Technology |
| Aziende private | 10 |
|---|---|
| Himax Taiwan, Inc. | |
| Himax Media Solutions, Inc. | |
| Himax Imaging Ltd. | |
Wisepal Technologies, Inc.
Wisepal Technologies, Inc. Electronics DistributorsDistribution Services Part of Himax Technologies, Inc., Wisepal Technologies, Inc. is a Taiwanese company that manufactures display drivers. The company is based in Miao-Li, Taiwan. Wisepal Technologies was acquired by Himax Technologies, Inc. on February 01, 2007 for $21.52 million. | Distribution Services |
| Harvest Investments Ltd. | |
| Himax Semiconductor Ltd. | |
| Credit Suisse First Boston Asia International (Cayman) Ltd. | |
CDIB Capital Group
 CDIB Capital Group Investment ManagersFinance CDIB Capital Group engages in the venture capital, and investment banking industries. Its business activities include industrial investment, asset management, own capital investment assets, activated assets, and international investment. The company was founded in 1959 and is headquartered in Taipei, Taiwan. | Finance |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
- Borsa valori
- Insiders
- Max Chan
- Esperienza
